High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients
Open Access
- 23 March 2010
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 126 (11), 2635-2643
- https://doi.org/10.1002/ijc.24989
Abstract
Regulatory T cells (Treg) inhibit the generation of host‐versus‐tumor immunity via suppression of tumor‐specific effector T‐cell responses and development of immune tolerance to neoplastic cells. The transcription factor forkhead box P3 (FOXP3) is an intracellular key molecule for Treg development and function and is considered to represent the most specific Treg cell marker. The aim of this study was to analyze the frequency and prognostic impact of tumor‐infiltrating FOXP3+ Treg in colorectal cancer (CRC) stratified by mismatch‐repair (MMR) status. Using the tissue microarray technique, 1,420 tumor samples were immunohistochemically stained for FOXP3 and stratified into 1,197 MMR‐proficient and 223 MMR‐deficient CRCs. Additionally, the 1,197 MMR‐proficient CRCs were randomized into 2 subgroups (Test Groups 1 and 2; n = 613 and 584, respectively). In both MMR‐proficient CRC subgroups high frequency tumor‐infiltrating FOXP3+ Treg was associated with early T stage (p = 0.001 and p = 0.01 and 0.045) and increased 5‐year survival rate (p = 0.004 and + Treg and absence of lymph node involvement (p = 0.023), absence of vascular invasion (p = 0.023) and improved 5‐year survival rate (p = 0.029) could be detected. In a multivariable analysis including age, gender, T stage, N stage, tumor grade, vascular invasion, and tumor border configuration, a high FOXP3+ Treg frequency was an independent prognostic factor in both MMR‐proficient CRC subsets (p = 0.019 and p = 0.007), but not in the MMR‐deficient CRCs (p = 0.13). Therefore, high frequency of tumor‐infiltrating FOXP3+ Treg is associated with early T stage and independently predicts improved disease‐specific survival in MMR‐proficient CRC patients.Keywords
This publication has 45 references indexed in Scilit:
- Regulatory T cells and cancerCurrent Opinion in Immunology, 2007
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Effector Memory T Cells, Early Metastasis, and Survival in Colorectal CancerNew England Journal of Medicine, 2005
- The Expression of the Regulatory T Cell–Specific Forkhead Box Transcription Factor FoxP3 Is Associated with Poor Prognosis in Ovarian CancerClinical Cancer Research, 2005
- Cancer Risk in Hereditary Nonpolyposis Colorectal Cancer Syndrome: Later Age of OnsetGastroenterology, 2005
- Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-selfNature Immunology, 2005
- Systematic Review of Microsatellite Instability and Colorectal Cancer PrognosisJournal of Clinical Oncology, 2005
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- High Prevalence of Activated Intraepithelial Cytotoxic T Lymphocytes and Increased Neoplastic Cell Apoptosis in Colorectal Carcinomas with Microsatellite InstabilityThe American Journal of Pathology, 1999
- Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated reviewGastroenterology, 1993